| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.0B | $5.2B | $4.6B | $4.8B | $1.1B | $1.0B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | $0.9B | — | — | — | — | — | — |
| Net Income | $0.7B | $0.7B | $0.5B | $0.7B | $0.8B | $0.5B | $0.1B | $0.1B |
| EPS (Basic) | $6.25 | $6.67 | $4.55 | $5.74 | $7.34 | $1.70 | $1.79 | $1.56 |
| EPS (Diluted) | $5.87 | $6.25 | $4.28 | $5.32 | $6.66 | $1.55 | $1.62 | $1.38 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $41.3B | $39.9B | $37.7B | $37.2B | $34.0B | $26.6B | $24.6B | $24.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.3B | $2.6B | $3.4B | $2.2B | $2.0B | $2.3B | $1.1B | $1.9B |
| Total Liabilities | $35.3B | $34.2B | $32.4B | $31.9B | $29.0B | $22.4B | $20.9B | $21.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | $4.2B | $3.6B | $3.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.5B | $0.5B | $1.2B | $0.9B | $1.7B | $0.6B | $0.5B |
| Investing Cash Flow | $-1.6B | $-2.3B | $1.0B | $-4.3B | $-7.0B | $-1.7B | $-0.4B | $-1.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.1B | $1.0B | $-0.3B | $3.2B | $5.8B | $1.2B | $-1.1B | $1.7B |